Glucocorticoid receptor overexpression in forebrain: A mouse model of increased emotional lability

被引:190
作者
Wei, Q
Lu, XY
Liu, L
Schafer, G
Shieh, KR
Burke, S
Robinson, TE
Watson, SJ
Seasholtz, AF
Akil, H
机构
[1] Univ Michigan, Mental Hlth Res Inst, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA
关键词
D O I
10.1073/pnas.0402208101
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The molecular mechanisms that control the range and stability of emotions are unknown, yet this knowledge is critical for understanding mood disorders, especially bipolar illness. Here, we show that the glucocorticoid receptor (GR) modulates these features of emotional responsiveness. We generated transgenic mice overexpressing GR specifically in forebrain. These mice display a significant increase in anxiety-like and depressant-like behaviors relative to wild type. Yet, they are also supersensitive to antidepressants and show enhanced sensitization to cocaine. Thus, mice overexpressing GR in forebrain have a consistently wider than normal range of reactivity in both positive and negative emotionality tests. This phenotype is associated, in specific brain regions, with increased expression of genes relevant to emotionality: corticotropin-releasing hormone, serotonin, norepinephrine and dopamine transporters, and 5-hydroxytryptamine(1A) receptor. Thus, GR overexpression in forebrain causes higher "emotional lability" secondary to a unique pattern of molecular regulation. This finding suggests that natural variations in GR gene expression can contribute to the fine-tuning of emotional stability or lability and may play a role in bipolar disorder.
引用
收藏
页码:11851 / 11856
页数:6
相关论文
共 36 条
[1]  
AKIL H, 1995, 4 GENERATION PROGR, P773
[2]  
AKISKAL HS, 1995, ARCH GEN PSYCHIAT, V52, P114
[3]   Endocrine profile and neuroendocrine challenge tests in transgenic mice expressing antisense RNA against the glucocorticoid receptor [J].
Barden, N ;
Stec, ISM ;
Montkowski, A ;
Holsboer, F ;
Reul, JMHM .
NEUROENDOCRINOLOGY, 1997, 66 (03) :212-220
[4]   An open label trial of C-1073 (mifepristone) for psychotic major depression [J].
Belanoff, JK ;
Rothschild, AJ ;
Cassidy, F ;
DeBattista, C ;
Baulieu, EE ;
Schold, C ;
Schatzberg, AF .
BIOLOGICAL PSYCHIATRY, 2002, 52 (05) :386-392
[5]   CURRENT ADVANCES AND TRENDS IN THE TREATMENT OF DEPRESSION [J].
BLIER, P ;
DEMONTIGNY, C .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (07) :220-226
[6]   THE MOUSE GLUCOCORTICOID RECEPTOR - MAPPING OF FUNCTIONAL DOMAINS BY CLONING, SEQUENCING AND EXPRESSION OF WILD-TYPE AND MUTANT RECEPTOR PROTEINS [J].
DANIELSEN, M ;
NORTHROP, JP ;
RINGOLD, GM .
EMBO JOURNAL, 1986, 5 (10) :2513-2522
[7]   Brain corticosteroid receptor balance in health and disease [J].
De Kloet, ER ;
Vreugdenhil, E ;
Oitzl, MS ;
Joëls, M .
ENDOCRINE REVIEWS, 1998, 19 (03) :269-301
[8]  
Dijkstra I, 1998, J NEUROSCI, V18, P3909
[9]   Use of antidepressants to treat depression in bipolar disorder [J].
El-Mallakh, RS ;
Karippot, A .
PSYCHIATRIC SERVICES, 2002, 53 (05) :580-584
[10]   The corticosteroid receptor hypothesis of depression [J].
Holsboer, F .
NEUROPSYCHOPHARMACOLOGY, 2000, 23 (05) :477-501